Medical Marketing and Media

Professional Media Articles

SaaS spurs health media M&A blitz

Matthew Arnold February 01, 2012

WebMD's non-sale was the big story in digital health media last month, but the buzz in the space is all around software-as-a-service firms, says media banker Berkery Noyes

Tamiflu review raises questions

Marc Iskowitz February 01, 2012

A systematic review of Roche's antiviral drug Tamiflu appearing in last month's Cochrane Library has led to questions about the data's efficacy, as well as Roche's commitment to provide sufficient data.

NEJM celebrates 200 years

Marc Iskowitz February 01, 2012

The New England Journal of Medicine celebrates its 200th aniversary by producing a series of review articles and perspective pieces by established authors

Professional Media briefs

Marc Iskowitz February 01, 2012

News on Archives of Neurology, Science, Journal of Pharmacokinetics and Pharmacodynamics and The Ocular Surface

Genentech hedged early on Avastin

Marc Iskowitz January 01, 2012

FDA commissioner Margaret Hamburg's final decision to rescind Avastin's indication for metastatic breast cancer came in November. But ad spending to support the brand had dropped sharply more than a year earlier.

83% of pharma's trials published

Marc Iskowitz January 01, 2012

More than eight out of 10 pharma-sponsored clinical trials made it into a peer-reviewed journal, a 23% increase over the 2008 rate, researchers showed.